Rocket Pharmaceuticals (RCKT) PT Raised to $42 at Oppenheimer Following Pipeline Update
Tweet Send to a Friend
Oppenheimer analyst Esther Rajavelu raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $42.00 (from $36.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
